---
schema_version: "secwatch.filing_event.v1"
accession: "0001125345-26-000045"
form_type: "8-K"
ticker: "MGNX"
cik: "0001125345"
company_name: "MACROGENICS INC"
filed_at: "2026-07-07T20:30:13+00:00"
generated_at: "2026-07-07T20:31:29.512221+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MacroGenics completes $122.5M sale of GMP manufacturing to Bora Pharmaceuticals

## Summary
- Closed sale of GMP manufacturing (CDMO) to Bora Pharmaceuticals for $122.5M cash, subject to post-closing adjustments.
- Bora assumes Rockville, MD facility and Frederick, MD warehouse; ~140 former MacroGenics employees hired by Bora.
- MacroGenics enters supply agreement with Bora for process development and drug substance production for pipeline.
- Pro forma cash and equivalents rise to $177.2M from $66.5M; estimated gain on sale of $106.1M recorded.
- Up to $5M in contingent consideration possible upon manufacturing milestones in 2027-2028.

## SEC filing metadata
- accession: 0001125345-26-000045
- form_type: 8-K
- ticker: MGNX
- cik: 0001125345
- company_name: MACROGENICS INC
- filed_at: 2026-07-07T20:30:13+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000045/0001125345-26-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000045/mgnx-20260630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001125345-26-000045
- JSON: https://secwatch.observer/filing/0001125345-26-000045.json
- Plain text: https://secwatch.observer/filing/0001125345-26-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.